Back
Sarepta Therapeutics Stock Predictions
Sponsored
SRPT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
130.47
Seasonality Move:
14.88%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 34% based on the past 27 years of stock performance.
- Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. - SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 34% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
78.67
Prediction Charts
Market Cap:
12.47B
Price in USD:
130.50
Volume:
3.37M
Beta:
1.06
Technical Analysis
SMA50:
121.92
SMA100:
130.74
SMA200:
129.99
52-Wk Change:
57.48%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 130.50 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-7 | 132.40 | 120.42 | 133.00 | 117.52 |
Nov-8 | 120.50 | 121.61 | 121.96 | 116.32 |
Nov-11 | 121.88 | 117.79 | 122.63 | 117.53 |
Nov-12 | 118.00 | 114.29 | 118.73 | 114.12 |
Nov-13 | 113.63 | 112.48 | 116.30 | 111.53 |
Nov-14 | 112.58 | 109.11 | 112.58 | 109.01 |
Nov-15 | 108.54 | 104.54 | 108.70 | 102.57 |
Nov-18 | 102.88 | 104.67 | 105.98 | 102.16 |
Nov-19 | 104.38 | 106.62 | 106.99 | 103.63 |
Nov-20 | 110.46 | 110.86 | 111.38 | 108.72 |
Nov-21 | 110.87 | 110.50 | 111.78 | 109.03 |
Nov-22 | 110.68 | 114.23 | 114.83 | 110.50 |
Nov-25 | 113.06 | 114.65 | 115.30 | 113.00 |
Nov-26 | 116.11 | 130.50 | 131.00 | 115.75 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.